Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
- PMID: 38298974
- PMCID: PMC10830179
- DOI: 10.1155/2024/9787343
Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
Abstract
[This retracts the article DOI: 10.1155/2022/1348855.].
Copyright © 2024 Emergency Medicine International.
Retraction of
-
Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema.Emerg Med Int. 2022 May 18;2022:1348855. doi: 10.1155/2022/1348855. eCollection 2022. Emerg Med Int. 2022. Retraction in: Emerg Med Int. 2024 Jan 24;2024:9787343. doi: 10.1155/2024/9787343. PMID: 35646399 Free PMC article. Retracted.
References
-
- Zhu Y., Li J., Yu S., Mao B., Ying J. Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema. Emergency Medicine International . 2022;2022:7. doi: 10.1155/2022/1348855.1348855 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
